Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Rizza

Showing results (151-160 of 314) with videos related to

Pageof 32
Sort By:
Mayo Clinic Proceedings|March 1, 1994
Effects of systemic delivery of insulin on plasma lipids and lipoprotein concentrations in pancreas transplant recipientsH H Katz, T T Nguyen, J A Velosa, et al.
Diabetologia|October 16, 2002
Lack of effect of exendin-4 and glucagon-like peptide-1-(7,36)-amide on insulin action in non-diabetic humansA Vella, P Shah, A S Reed, et al.
The Journal of Clinical Investigation|April 1, 1989
Influence of body fat distribution on free fatty acid metabolism in obesityM D Jensen, M W Haymond, R A Rizza, et al.
Hypertension (Dallas, Tex. : 1979)|August 27, 1998
Insulin and insulin-like growth factor-I cause coronary vasorelaxation in vitroD Hasdai, R A Rizza, D R Holmes, et al.
American Journal of Physiology. Endocrinology and Metabolism|July 12, 2002
Effect of enteral vs. parenteral glucose delivery on initial splanchnic glucose uptake in nondiabetic humansAdrian Vella, Pankaj Shah, Rita Basu, et al.
Diabetologia|July 7, 2001
Type I diabetes mellitus does not alter initial splanchnic glucose extraction or hepatic UDP-glucose flux during enteral glucose administrationA Vella, P Shah, R Basu, et al.
Advances in Experimental Medicine and Biology|October 20, 2012
Do the carotid bodies modulate hypoglycemic counterregulation and baroreflex control of blood pressure in humans?Erica A Wehrwein, Timothy B Curry, Ananda Basu, et al.
The Journal of Clinical Investigation|December 1, 1994
Assessment of insulin action and glucose effectiveness in diabetic and nondiabetic humansA A Alzaid, S F Dinneen, D J Turk, et al.
Diabetes|December 28, 2002
Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetesAlexandra E Butler, Juliette Janson, Susan Bonner-Weir, et al.
Diabetes|December 10, 1997
Assessment of hepatic sensitivity to glucagon in NIDDM: use as a tool to estimate the contribution of the indirect pathway to nocturnal glycogen synthesisM F Nielsen, S Wise, S F Dinneen, et al.
Pageof 32

Showing results (151-160 of 314) with videos related to

Sort By:
Pageof 32
Mayo Clinic Proceedings|March 1, 1994
Effects of systemic delivery of insulin on plasma lipids and lipoprotein concentrations in pancreas transplant recipientsH H Katz, T T Nguyen, J A Velosa, et al.
Diabetologia|October 16, 2002
Lack of effect of exendin-4 and glucagon-like peptide-1-(7,36)-amide on insulin action in non-diabetic humansA Vella, P Shah, A S Reed, et al.
The Journal of Clinical Investigation|April 1, 1989
Influence of body fat distribution on free fatty acid metabolism in obesityM D Jensen, M W Haymond, R A Rizza, et al.
Hypertension (Dallas, Tex. : 1979)|August 27, 1998
Insulin and insulin-like growth factor-I cause coronary vasorelaxation in vitroD Hasdai, R A Rizza, D R Holmes, et al.
American Journal of Physiology. Endocrinology and Metabolism|July 12, 2002
Effect of enteral vs. parenteral glucose delivery on initial splanchnic glucose uptake in nondiabetic humansAdrian Vella, Pankaj Shah, Rita Basu, et al.
Diabetologia|July 7, 2001
Type I diabetes mellitus does not alter initial splanchnic glucose extraction or hepatic UDP-glucose flux during enteral glucose administrationA Vella, P Shah, R Basu, et al.
Advances in Experimental Medicine and Biology|October 20, 2012
Do the carotid bodies modulate hypoglycemic counterregulation and baroreflex control of blood pressure in humans?Erica A Wehrwein, Timothy B Curry, Ananda Basu, et al.
The Journal of Clinical Investigation|December 1, 1994
Assessment of insulin action and glucose effectiveness in diabetic and nondiabetic humansA A Alzaid, S F Dinneen, D J Turk, et al.
Diabetes|December 28, 2002
Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetesAlexandra E Butler, Juliette Janson, Susan Bonner-Weir, et al.
Diabetes|December 10, 1997
Assessment of hepatic sensitivity to glucagon in NIDDM: use as a tool to estimate the contribution of the indirect pathway to nocturnal glycogen synthesisM F Nielsen, S Wise, S F Dinneen, et al.
Pageof 32